{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:21:02Z","timestamp":1790857262515,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102922","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:06:34Z","timestamp":1774368394000},"page":"102922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Melatonin-loaded MSCs-derived exosomes as therapeutic carriers to alleviate levodopa-induced dyskinesia in Parkinson's disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nano.2026.102922_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nano.2026.102922_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.nano.2026.102922_bb0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.nano.2026.102922_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.nano.2026.102922_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40263-015-0247-x","article-title":"Impact of pharmacotherapy on quality of life in patients with Parkinson\u2019s disease","volume":"29","author":"Martinez-Martin","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nano.2026.102922_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/JEP.S161782","article-title":"Effects of blackberry (Morus nigra) fruit juice on levodopa-induced dyskinesia in a mice model of Parkinson\u2019s disease","volume":"10","author":"Fahimi","year":"2018","journal-title":"J Exp Pharmacol"},{"key":"10.1016\/j.nano.2026.102922_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105878","article-title":"Melatonin supplementation and the effects on clinical and metabolic status in Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"195","author":"Daneshvar Kakhaki","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp-2016-314601","article-title":"Neuroendocrine abnormalities in Parkinson\u2019s disease","volume":"88","author":"De Pablo-Fern\u00e1ndez","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nano.2026.102922_bb0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment","volume":"83","author":"Thanvi","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.nano.2026.102922_bb0050","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102922_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040218","article-title":"Exosomes and exosome-inspired vesicles for targeted drug delivery","volume":"10","author":"Antimisiaris","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102922_bb0060","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1002\/asia.202000873","article-title":"Recent progress on the isolation and detection methods of exosomes","volume":"15","author":"Jiang","year":"2020","journal-title":"Chem Asian J"},{"key":"10.1016\/j.nano.2026.102922_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101771","article-title":"Exosome nanovesicles: a potential carrier for therapeutic delivery","volume":"49","author":"Chavda","year":"2023","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.nano.2026.102922_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biotechadv.2012.08.008","article-title":"Exosomes for drug delivery - a novel application for the mesenchymal stem cell","volume":"31","author":"Lai","year":"2013","journal-title":"Biotechnol Adv"},{"issue":"4","key":"10.1016\/j.nano.2026.102922_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"issue":"February","key":"10.1016\/j.nano.2026.102922_bb0080","first-page":"1","article-title":"MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury","volume":"11","author":"Yang","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"June","key":"10.1016\/j.nano.2026.102922_bb0085","first-page":"16","article-title":"Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: risk-benefit profile and next steps for the market access","volume":"29","author":"Giovannelli","year":"2023","journal-title":"Bioact Mater"},{"issue":"October 2023","key":"10.1016\/j.nano.2026.102922_bb0090","first-page":"124","article-title":"Exosome regulation of immune response mechanism: pros and cons in immunotherapy","volume":"32","author":"Essola","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.nano.2026.102922_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148262","article-title":"MSCs-derived exosomes containing miR-486-5p attenuate cerebral ischemia and reperfusion (I\/R) injury","volume":"906","author":"Zhu","year":"2024","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.nano.2026.102922_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15288","article-title":"Exosomes in Parkinson disease","volume":"157","author":"Pinnell","year":"2021","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11064-020-02972-w","article-title":"Antioxidants and neuron-astrocyte interplay in brain physiology: melatonin, a neighbor to rely on","volume":"46","author":"Gonzalez","year":"2021","journal-title":"Neurochem Res"},{"issue":"8","key":"10.1016\/j.nano.2026.102922_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0183090","article-title":"Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases","volume":"12","author":"L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-079X.2011.00927.x","article-title":"Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats","volume":"52","author":"Sae-Ung","year":"2012","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nano.2026.102922_bb0120","article-title":"Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson\u2019s disease","volume":"15","author":"Ma","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res"},{"issue":"1\u20133","key":"10.1016\/j.nano.2026.102922_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.nano.2026.102922_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.nano.2026.102922_bb0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J Pineal Res"},{"issue":"1\u20132","key":"10.1016\/j.nano.2026.102922_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03106-7","article-title":"Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway","volume":"921","author":"Morgan","year":"2001","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.nano.2026.102922_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03033256","article-title":"Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum","volume":"1","author":"van der Schyf","year":"1999","journal-title":"Neurotox Res"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone parkinson\u2019s disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.nano.2026.102922_bb0160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbrc.2016.07.093","article-title":"Effects and mechanisms of melatonin on the proliferation and neural differentiation of PC12 cells","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0170","first-page":"1","article-title":"Melatonin attenuates MPP+-induced autophagy via heat shock protein in the Parkinson\u2019s disease mouse model","volume":"13","author":"Guo","year":"2025","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.nano.2026.102922_bb0175","doi-asserted-by":"crossref","DOI":"10.5812\/ans.94041","article-title":"Endometrial mesenchymal stem cell-derived exosome promote endothelial cell angiogenesis in a dose dependent manner: a new perspective on regenerative medicine and cell-free therapy","volume":"6","author":"Taghdiri Nooshabadi","year":"2019","journal-title":"Arch Neurosci"},{"key":"10.1016\/j.nano.2026.102922_bb0180","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.2147\/IJN.S218988","article-title":"A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro","volume":"14","author":"Wei","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102922_bb0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biocel.2016.09.002","article-title":"Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury","volume":"79","author":"Kalani","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.nano.2026.102922_bb0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.nano.2026.102922_bb0200","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/cbic.201400043","article-title":"Exosomes and microvesicles: identification and targeting by particle size and lipid chemical probes","volume":"15","author":"Kastelowitz","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.nano.2026.102922_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","article-title":"Controlled drug release from pharmaceutical nanocarriers","volume":"125","author":"Lee","year":"2015","journal-title":"Chem Eng Sci"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejpb.2008.01.007","article-title":"Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process","volume":"69","author":"Kim","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102922_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijbiomac.2021.12.074","article-title":"Proliferation and differentiation study of melatonin functionalized polycaprolactone\/gelatin electrospun fibrous scaffolds for nerve tissue engineering","volume":"197","author":"Chen","year":"2022","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.nano.2026.102922_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151251","article-title":"Melatonin finely tunes proliferation and senescence in hematopoietic stem cells","volume":"101","author":"Cruciani","year":"2022","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"10.1016\/j.nano.2026.102922_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110844","article-title":"Melatonin promotes proliferation of Inner Mongolia cashmere goat hair follicle papilla cells through Wnt10b","volume":"116","author":"Gong","year":"2024","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.nano.2026.102922_bb0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-079X.2004.00157.x","article-title":"Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats","volume":"37","author":"Kim","year":"2004","journal-title":"J Pineal Res"},{"issue":"1\u20133","key":"10.1016\/j.nano.2026.102922_bb0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.04.039","article-title":"Neuroprotective effect of catalpol against MPP+-induced oxidative stress in mesencephalic neurons","volume":"568","author":"Tian","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"January","key":"10.1016\/j.nano.2026.102922_bb0240","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ibneur.2024.03.003","article-title":"Melatonin at repeated doses alleviates hyperglycemia-exacerbated cerebral ischemia-reperfusion injury at 72 h via anti-inflammation and anti-apoptosis","volume":"16","author":"Xu","year":"2024","journal-title":"IBRO Neurosci Rep"},{"issue":"5","key":"10.1016\/j.nano.2026.102922_bb0245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cell.2005.05.019","article-title":"Apoptotic pathways: ten minutes to dead","volume":"121","author":"Green","year":"2005","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.nano.2026.102922_bb0250","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archpsyc.58.11.1049","article-title":"Melatonin treatment for tardive dyskinesia","volume":"58","author":"Shamir","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"February","key":"10.1016\/j.nano.2026.102922_bb0255","first-page":"1","article-title":"Effects of melatonin on neurobehavior and cognition in a cerebral palsy model of plppr5\u2212\/\u2212 mice","volume":"12","author":"Sun","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.nano.2026.102922_bb0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.physbeh.2013.06.015","article-title":"Melatonin ameliorates chronic mild stress induced behavioral dysfunctions in mice","volume":"119","author":"Haridas","year":"2013","journal-title":"Physiol Behav"},{"issue":"6","key":"10.1016\/j.nano.2026.102922_bb0265","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0091-3057(81)90048-4","article-title":"The effects of melatonin on open field behavior","volume":"15","author":"Golus","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-079X.2008.00568.x","article-title":"Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice","volume":"45","author":"Kilic","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nano.2026.102922_bb0275","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/00001756-199807130-00043","article-title":"Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system","volume":"9","author":"Kim","year":"1998","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(02)02551-9","article-title":"Protective effect of melatonin in a chronic experimental model of Parkinson\u2019s disease","volume":"943","author":"Antol\u00edn","year":"2002","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0285","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1096\/fj.00-0129com","article-title":"Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity","volume":"15","author":"Dabbeni-Sala","year":"2001","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","article-title":"Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine in the mouse nigrostriatum","volume":"36","author":"Thomas","year":"2004","journal-title":"J Pineal Res"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0024-3205(96)00606-6","article-title":"Melatonin is protective against MPTP-induced striatal and hippocampal lesions","volume":"60","author":"Acu\u00f1a-Castroviejo","year":"1996","journal-title":"Life Sci"},{"issue":"18","key":"10.1016\/j.nano.2026.102922_bb0300","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1097\/00001756-199812210-00022","article-title":"Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats","volume":"9","author":"Joo","year":"1998","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.nano.2026.102922_bb0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(98)00170-0","article-title":"Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats","volume":"245","author":"Jin","year":"1998","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.nano.2026.102922_bb0310","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/npp.2009.46","article-title":"Melatonin modulates cell survival of new neurons in the hippocampus of adult mice","volume":"34","author":"Ram\u00edrez-Rodr\u00edguez","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nano.2026.102922_bb0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-4886(03)00363-7","article-title":"Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson\u2019 s disease","volume":"185","author":"Paul","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nano.2026.102922_bb0320","first-page":"186","article-title":"Minireview studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson\u2019s disease","volume":"200","author":"Bjo","year":"1997"},{"issue":"7","key":"10.1016\/j.nano.2026.102922_bb0325","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-0034-1384587","article-title":"A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women","volume":"47","author":"Mesri Alamdari","year":"2014","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0330","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clnu.2017.12.004","article-title":"Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Raygan","year":"2019","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.nano.2026.102922_bb0335","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00394-019-02123-0","article-title":"Melatonin supplementation and pro-inflammatory mediators: a systematic review and meta-analysis of clinical trials","volume":"59","author":"Zarezadeh","year":"2020","journal-title":"Eur J Nutr"},{"issue":"1","key":"10.1016\/j.nano.2026.102922_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10787-018-0539-0","volume":"27","author":"Bazyar","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"6923","key":"10.1016\/j.nano.2026.102922_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.308.6923.281","article-title":"Parkinson\u2019s disease and its management","volume":"308","author":"Hughes","year":"1994","journal-title":"BMJ"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:26:12Z","timestamp":1785709572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":69,"alternative-id":["S1549963426000237"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102922","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin-loaded MSCs-derived exosomes as therapeutic carriers to alleviate levodopa-induced dyskinesia in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102922"}}